duvelisib for r/r ptcl: updates from the primo trial
Published 3 years ago • 148 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
3:12
duvelisib plus romidepsin in r/r ptcl
-
1:23
findings from the ro-chop trial in patients with r/r ptcl
-
1:35
redirect results: afm13 in patients with cd30 r/r ptcl
-
1:35
long-term outcomes for patients with ptcl: 10-year follow-up analysis
-
4:03
novel agent therapies are improving r/r ptcl outcomes
-
2:39
the safety and efficacy of ibrutinib for the treatment of cll
-
1:31
speed revision 2024 a/l microbiology - introduction video
-
2:13
phase ii trial of split-dose r-chop for older patients with dlbcl
-
1:11
hdacis in treating r/r ptcl
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
1:35
pirtobrutinib in r/r fl: results from the bruin study
-
4:18
duvelisib in car t-cell therapy for cll
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
4:42
ptcl arising as a ptld: the efficacy of pralatrexate
-
1:06
pirtobrutinib in r/r mzl: insights from the bruin trial
-
2:57
lacutamab, an anti-kir3dl2 monoclonal antibody, in the treatment of r/r ptcl
-
2:41
improved outcomes in ptcl with the use of novel agents and transplantation
-
1:55
update on the phase i/ii bruin study
-
1:41
oral time-limited duvelisib/venetoclax in r/r cll
-
2:39
updates from the phase i/ii bruin study: pirtobrutinib in cll
-
1:56
updated results of phase i/ii bruin study: pirtobrutinib in covalent btk inhibitor pretreated mcl
-
1:00
bruin cll-322 update: fixed-duration pirtobrutinib plus vr vs vr in patients with r/r cll